That's only 10 points. BIIB has gained more than that just this week. If the next quarterly report is as good as the last one a 10-20% increase is likely (IMO)
As previously reported, BofA/Merrill added Biogen to the U.S. 1 List. The firm believes risk/reward is favorable ahead of the Tecfidera regulatory decision in Europe, regardless of the outcome, and sees 30% upside potential on a positive outcome and 15% downside on a negative decision. Shares are Buy rated with a $309 price target.
Hey bud, I worked for Biogen for two years as a senior protein formulations scientist at the Cambridge Mass Campus. As a matter of fact you can thank me in part for Liquid Avonex. I was the one who discovered the perfect biostability excipients which garnered FDA approval. Yeah me. So I probably know Biogen-Idec (now) better than anyone on this board - OK? So when that dude says INO is good, I agree. I worked with the technology before and and even made a presentation on it at Biogen as a possible project 11 yrs ago! Trouble is back then we were and they are still using Korean Hamsters for the IgG expressions and bactrium fermenting processes. Viral city! Delicate and old technology. What INO did to turn the biotech corner is brand new and super exciting to anyone with a science education. Synthetic DNA. IMO, INO is the best company in the business right now. And coupling it with electropoloration is a double whammy. Yes a pre-clinical penny pooper. Big deal. So was Acadia and or Sepracor when I was working for them and their IPO dropped from 6 dollars to .60 cents. Penny stock. Now look at them...So before you judge, do some heavy reading on the science and I suggest the Journal of Infectious Diseases or The New England Journal of Medicine. Two big Peer Review Guns. Remember, it's the people who make the company and not it's history. INO has some serious talent now. IMO
Sentiment: Strong Buy
on profits from their new MS drug Tecfedera alone, never mind the new research. MS patients are dropping the injectibles like mad and Tecfedera instead. 60% relapse rate and very safe AND it really helps. Believe me....I know....I take it. The couple of PML reports are misleading...people were weakened and sick from other drugs. Tecfedera is a life saver and new MS reversal drugs are in the pipeline.
Sentiment: Strong Buy